Lineage Cell Therapeutics Historical Earnings image   This LCTX historical earnings page last updated 3/21/2024
Lineage Cell Therapeutics Historical Revenue
PeriodHistorical Earnings DateGAAP
Q4 20233/7/20240.00B
Q3 202311/9/20230.00B
Q2 20238/10/20230.00B
Q1 20235/11/20230.00B
Q4 20223/9/20230.00B
Q3 202211/10/20220.00B
Q2 20228/11/20220.00B
Q1 20225/12/20220.01B
Q4 20213/10/20220.00B
Q3 202111/10/20210.00B
Q2 20218/12/20210.00B
Q1 20215/13/20210.00B
Q4 20203/11/20210.00B
Q3 202011/4/20200.00B
Q2 20208/6/20200.00B
Q1 20205/7/20200.00B
Q4 20193/12/20200.00B
Q3 201911/12/20190.00B
Q2 20198/8/20190.00B
Q1 20195/9/20190.00B
Q4 20183/14/20190.00B
Q3 201811/8/20180.00B
Q2 20188/2/20180.00B
Q1 20185/10/20180.00B
Q4 20173/15/20180.00B
Q3 201711/9/20170.00B
Q2 20178/2/20170.00B
Q1 20175/10/20170.00B
Q4 20163/16/20170.00B
Q3 201611/3/20160.00B
Q2 20168/9/20160.00B
Q1 20165/10/20160.00B
Q4 20153/29/20160.00B
Q3 201511/9/20150.00B
Q2 20158/10/20150.00B
Q1 20155/11/20150.00B
Q4 20143/11/20150.00B
Q3 201411/10/20140.00B
Q2 20148/12/20140.00B
Q1 20145/12/20140.00B
Q4 20133/17/20140.00B
Q3 201311/12/20130.00B
Q2 20138/9/20130.00B
Q1 20135/10/20130.00B
Q4 20123/18/20130.00B
Lineage Cell Therapeutics Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q4 20233/7/2024-0.030
Q3 202311/9/2023-0.040
Q2 20238/10/2023-0.030
Q1 20235/11/2023-0.030
Q4 20223/9/2023-0.030
Q3 202211/10/2022-0.040
Q2 20228/11/2022-0.040
Q1 20225/12/2022-0.040
Q4 20213/10/2022-0.170
Q3 202111/10/2021-0.050
Q2 20218/12/2021-0.030
Q1 20215/13/2021-0.010
Q4 20203/11/20210.010
Q3 202011/4/2020-0.050
Q2 20208/6/2020-0.040
Q1 20205/7/2020-0.060
Q4 20193/12/2020-0.030
Q3 201911/12/2019-0.110
Q2 20198/8/2019-0.200
Q1 20195/9/20190.300
Q4 20183/14/2019-0.36
Q3 201811/8/20180.53
Q2 20188/2/2018-0.03
Q1 20185/10/2018-0.5
Q4 20173/15/2018-0.58
Q3 201711/9/2017-0.08
Q2 20178/2/2017-0.11
Q1 20175/10/2017-0.08
Q4 20163/16/2017-0.05
Q3 201611/3/2016-0.09
Q2 20168/9/2016-0.11
Q1 20165/10/2016-0.19
Q4 20153/29/2016-0.13
Q3 201511/9/2015-0.18
Q2 20158/10/2015-0.12
Q1 20155/11/2015-0.13
Q4 20143/11/2015-0.14
Q3 201411/10/2014-0.12
Q2 20148/12/2014-0.16
Q1 20145/12/2014-0.14
Q4 20133/17/2014-0.35
Q3 201311/12/2013-0.16
Q2 20138/9/2013-0.14
Q1 20135/10/2013-0.15
Q4 20123/18/2013-0.12
What was the record high LCTX historical earnings result?
In terms of earnings or revenue, what is the best LCTX historical earnings result that Lineage Cell Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest LCTX historical earnings result was set in Q3 2018, when Lineage Cell Therapeutics posted results of 0.53/share. The most successful revenue quarter within our data set was Q1 2022 when Lineage Cell Therapeutics reported revenue of 0.01B.

What was the lowest Lineage Cell Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest LCTX has reported, and when?

✔️Accepted answer: Within our data set, the lowest LCTX historical earnings result was set in Q4 2017, when Lineage Cell Therapeutics posted results of -0.58/share. The smallest revenue quarter within our data set was Q4 2020 when Lineage Cell Therapeutics reported revenue of 0.00B.

On this page we presented the LCTX historical earnings date information for Lineage Cell Therapeutics. Reviewing that Lineage Cell Therapeutics Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2018, when LCTX posted gaap of 0.53/share. Meanwhile the lowest LCTX historical earnings result was in Q4 2017, when LCTX posted gaap of -0.58/share. Moving to Lineage Cell Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2022 when LCTX reported 0.01B in revenue, while the smallest revenue quarter was Q4 2020 when LCTX reported 0.00B in revenue.

For self directed investors doing their due diligence on LCTX or any other given stock, their research can benefit from looking into all of the Lineage Cell Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Lineage Cell Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for LCTX. Thanks for visiting, and the next time you need to research LCTX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: SRCL Insider Buying, VCKA Historical Stock Prices, TTI shares outstanding history.

 

Lineage Cell Therapeutics Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.